Scientists test drug mix for future breast cancer treatment
NCT ID NCT07229560
Summary
This early study tested how a common antifungal drug (itraconazole) affects the way the body processes a new experimental breast cancer drug (HRS-8080). Researchers gave both drugs to 16 healthy volunteers to measure drug levels in the blood and check for safety. The goal was to understand potential drug interactions before testing in cancer patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, 450052, China
Conditions
Explore the condition pages connected to this study.